Virios Therapeutics, Inc. (VIRI)
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
$5.41M
Mr. Gregory Duncan
5.00
Alpharetta, GA
Dec 17, 2020
-0.85
$-0.23
8.83
8.83
0.00%
-1.68
2.68
0.00
8.83
-143.54%
-109.96%
Similar stocks (10)
Immix Biopharma, Inc.
IMMX
SeaStar Medical Holding Corporation
ICU
CNS Pharmaceuticals, Inc.
CNSP
TransCode Therapeutics, Inc.
RNAZ
Sonnet BioTherapeutics Holdings, Inc.
SONN
Phio Pharmaceuticals Corp.
PHIO
ZyVersa Therapeutics, Inc.
ZVSA
Revelation Biosciences, Inc.
REVB
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (12)
Schwab Fundamental International Small Company Index ETF
FNDC
0.0559948878%
Schwab International Small-Cap Equity ETF
SCHC
0.0173257008%
Vanguard FTSE All-World ex-US Small Capital Index Fund
VSS
0.01%
SPDR Portfolio Europe ETF
SPEU
0.002149%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.001194%
Vanguard Developed Markets Index Fund
VEA
0%
Vanguard European Stock Index Fund
VGK
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total World Stock Index Fund
VT
0%
Vanguard Total Intl Stock Idx Fund
VTSNX
0%
Vanguard Extended Market Index Fund
VXF
0%
Vanguard Total Intl Stock Idx Fund
VXUS
0%
Similar stocks (10)
Immix Biopharma, Inc.
IMMX
SeaStar Medical Holding Corporation
ICU
CNS Pharmaceuticals, Inc.
CNSP
TransCode Therapeutics, Inc.
RNAZ
Sonnet BioTherapeutics Holdings, Inc.
SONN
Phio Pharmaceuticals Corp.
PHIO
ZyVersa Therapeutics, Inc.
ZVSA
Revelation Biosciences, Inc.
REVB
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (12)
Schwab Fundamental International Small Company Index ETF
FNDC
0.0559948878%
Schwab International Small-Cap Equity ETF
SCHC
0.0173257008%
Vanguard FTSE All-World ex-US Small Capital Index Fund
VSS
0.01%
SPDR Portfolio Europe ETF
SPEU
0.002149%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.001194%
Vanguard Developed Markets Index Fund
VEA
0%
Vanguard European Stock Index Fund
VGK
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total World Stock Index Fund
VT
0%
Vanguard Total Intl Stock Idx Fund
VTSNX
0%
Vanguard Extended Market Index Fund
VXF
0%
Vanguard Total Intl Stock Idx Fund
VXUS
0%